252 related articles for article (PubMed ID: 9933143)
21. Transducing system operated by adenosine A(2A) receptors to facilitate acetylcholine release in the rat hippocampus.
Rebola N; Oliveira CR; Cunha RA
Eur J Pharmacol; 2002 Nov; 454(1):31-8. PubMed ID: 12409002
[TBL] [Abstract][Full Text] [Related]
22. Differential development of adenosine A1 and A2b receptors in the rat duodenum.
Peachey JA; Hourani SM; Kitchen I
Br J Pharmacol; 1996 Nov; 119(5):949-58. PubMed ID: 8922745
[TBL] [Abstract][Full Text] [Related]
23. [125I]4-aminobenzyl-5'-N-methylcarboxamidoadenosine (125I)AB-MECA) labels multiple adenosine receptor subtypes in rat brain.
Shearman LP; Weaver DR
Brain Res; 1997 Jan; 745(1-2):10-20. PubMed ID: 9037389
[TBL] [Abstract][Full Text] [Related]
24. KW-3902, a selective high affinity antagonist for adenosine A1 receptors.
Nonaka H; Ichimura M; Takeda M; Kanda T; Shimada J; Suzuki F; Kase H
Br J Pharmacol; 1996 Apr; 117(8):1645-52. PubMed ID: 8732272
[TBL] [Abstract][Full Text] [Related]
25. Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors.
van Rhee AM; Jiang JL; Melman N; Olah ME; Stiles GL; Jacobson KA
J Med Chem; 1996 Jul; 39(15):2980-9. PubMed ID: 8709132
[TBL] [Abstract][Full Text] [Related]
26. Adenosine A2a receptors increase arterial endothelial cell nitric oxide.
Li Jm; Fenton RA; Wheeler HB; Powell CC; Peyton BD; Cutler BS; Dobson JG
J Surg Res; 1998 Dec; 80(2):357-64. PubMed ID: 9878338
[TBL] [Abstract][Full Text] [Related]
27. Functional expression of adenosine A2A and A3 receptors in the mouse dendritic cell line XS-106.
Dickenson JM; Reeder S; Rees B; Alexander S; Kendall D
Eur J Pharmacol; 2003 Aug; 474(1):43-51. PubMed ID: 12909194
[TBL] [Abstract][Full Text] [Related]
28. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
Alexander SP; Curtis AR; Kendall DA; Hill SJ
Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
[TBL] [Abstract][Full Text] [Related]
29. A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig.
Haynes JM; Alexander SP; Hill SJ
Br J Pharmacol; 1998 Oct; 125(3):570-6. PubMed ID: 9806342
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells.
Fredholm BB; Irenius E; Kull B; Schulte G
Biochem Pharmacol; 2001 Feb; 61(4):443-8. PubMed ID: 11226378
[TBL] [Abstract][Full Text] [Related]
31. Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors.
Kull B; Arslan G; Nilsson C; Owman C; Lorenzen A; Schwabe U; Fredholm BB
Biochem Pharmacol; 1999 Jan; 57(1):65-75. PubMed ID: 9920286
[TBL] [Abstract][Full Text] [Related]
32. Selective adenosine A2A receptor antagonists.
Ongini E; Monopoli A; Cacciari B; Baraldi PG
Farmaco; 2001; 56(1-2):87-90. PubMed ID: 11347973
[TBL] [Abstract][Full Text] [Related]
33. An endogenous A2B adenosine receptor coupled to cyclic AMP generation in human embryonic kidney (HEK 293) cells.
Cooper J; Hill SJ; Alexander SP
Br J Pharmacol; 1997 Oct; 122(3):546-50. PubMed ID: 9351513
[TBL] [Abstract][Full Text] [Related]
34. Failure of CGS15943A to block the hypotensive action of agonists acting at the adenosine A3 receptor.
Patel M; Sheehan MJ; Strong P
Br J Pharmacol; 1994 Nov; 113(3):741-8. PubMed ID: 7858863
[TBL] [Abstract][Full Text] [Related]
35. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
Cunha RA; Johansson B; Constantino MD; Sebastião AM; Fredholm BB
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):261-71. PubMed ID: 8692280
[TBL] [Abstract][Full Text] [Related]
36. Adenosine analogues relax guinea-pig taenia caeci via an adenosine A2B receptor and a xanthine-resistant site.
Prentice DJ; Hourani SM
Eur J Pharmacol; 1997 Mar; 323(1):103-6. PubMed ID: 9105884
[TBL] [Abstract][Full Text] [Related]
37. G protein coupling of CGS 21680 binding sites in the rat hippocampus and cortex is different from that of adenosine A1 and striatal A2A receptors.
Cunha RA; Constantino MD; Ribeiro JA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):295-302. PubMed ID: 10344528
[TBL] [Abstract][Full Text] [Related]
38. Effects of the new A2 adenosine receptor antagonist 8FB-PTP, an 8 substituted pyrazolo-triazolo-pyrimidine, on in vitro functional models.
Dionisotti S; Conti A; Sandoli D; Zocchi C; Gatta F; Ongini E
Br J Pharmacol; 1994 Jun; 112(2):659-65. PubMed ID: 8075885
[TBL] [Abstract][Full Text] [Related]
39. Adenosine inhibits a non-inactivating K+ current in bovine adrenal cortical cells by activation of multiple P1 receptors.
Xu L; Enyeart JJ
J Physiol; 1999 Nov; 521 Pt 1(Pt 1):81-97. PubMed ID: 10562336
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
